Clemens A. Schmitt, MD

Professor
Department of Hematology and Internal Oncology, Kepler University Hospital, Johannes Kepler University, Austria

N/A

Poster(s):

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial